转自：成都日报锦观 淀粉含量超越水稻 蛋白含量堪比大豆 马斯克拿它当太空粮食供给 浮萍什么来头？ 第三届浮萍资源开发与利用研讨会在蓉举办 "雨过浮萍合，蛙声满四邻。"近千年前，苏轼以雨后浮萍的动态，勾勒出雨后生机盎然的乡村。千年之后，中国科学家正在深入挖掘浮萍在粮 食安全、资源循环利用以及生物制造领域的应用价值。 面对这些风险与挑战，应该如何破题？在赵海看来，浮萍的应用研究也许是破题的关键路径之一，"浮萍在粮食安全、资源循环利用和生物制 造领域具有广泛的应用前景。" "从突破粮食困境的角度来讲，浮萍作为新食物资源，其优势十分明显。"赵海分析道，浮萍是水生植物，不与粮争地，且环境稳定性强；生长 速度快（可实现指数级生长），不仅产量高还能全年生长； （近）二维生长，易于调控，便于开展垂直种植及工业化生产。 浮萍，能耐有多大？ 12月19日至21日，以"浮萍：生物制造与替代蛋白开发——从基础到应用"为主题的第三届浮萍资源开发与利用研讨会在蓉举办。 浮萍，有什么用？ 欧洲食品安全局（EFSA）今年正式批准浮萍在欧盟内作为新鲜蔬菜生产和消费；马斯克的Spacex公司将浮萍作为太空食物补给，送往国际空 间站……浮萍，这种 ...

赛迪研究院信息化与软件产业研究所人工智能研究室副主任刘丽超介绍，2025年，我国人工智能产 业规模呈现爆发式增长态势。截至9月，我国人工智能核心产业规模超过9000亿元，人工智能企业数量 超过5300家，国家级人工智能专精特新"小巨人"企业超400家。 赛迪研究院日前发布的《2026年我国人工智能产业发展形势展望》预计，2026年，我国人工智能产 业将维持高速增长态势。其中，智能算力占比有望突破35%，国产芯片将在部分场景实现规模化应用。 此外，同步发布的《2026年我国未来产业发展形势展望》预计，明年我国未来产业发展将迎来重要 转折点，多赛道有望实现从技术突破到产业化落地的关键跨越。如量子科技逐步从实验室走向特定场景 应用；生物制造技术在医药研发、农业育种等领域的应用深度不断拓展；可控核聚变进入工程可行性验 证关键阶段。（记者周圆） 【纠错】 【责任编辑:焦鹏】 报告预计，明年我国大模型技术能力将聚焦物理认知深化、推理效能提升、架构范式革新等关键维 度，迎来进一步升级；数据要素质量与开放度同步提升，高质量中文语料与行业数据集建设提速；人工 智能技术从前端服务环节加速向研发、生产等核心领域延伸。 ...

www.leadleo.com 2025年中国化妆品新原料行业短报告： "妆"备竞赛升级，谁最有可能定义 下一代超级单品？ China New Cosmetic Ingredients Industry 中国化粧品新原料業界 概览标签：化妆品原料、化妆品备案新原料 1 ©2025 LeadLeo 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均 系头豹研究院独有的高度机密性文件（在报告中另行标明出处者除外 ）。 ，任何人不得以任何方式擅自复制 、再造、传播、出版、引用、改编、汇编本报告内容，若有违反上述 约定的行为发生，头豹研究院保留采取法律措施，追究相关人员责任 的权利。头豹研究院开展的所有商业活动均使用"头豹研究院"或"头豹 "的商号、商标，头豹研究院无任何前述名称之外的其他分支机构， 也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 www.leadleo.com 400-072-5588 #6C0000 #7C0000 #940000 #C00000 #E00000 #E994A6 #F3C3CD 标准色 #9A0000 衍生色 #D4C4C4 #BFBFBF #D9D9D9 #9 ...

Core Viewpoint - Anhui Huaheng Biotechnology Co., Ltd. (Huaheng Bio) has submitted an application for listing on the Hong Kong Stock Exchange, with Huatai International as the sole sponsor [1]. Company Overview - Huaheng Bio is a pioneer in synthetic biology, focusing on the research, large-scale production, and commercialization of bio-based products through biomanufacturing technology. The company has established a leading position in the industry over the past 20 years [3]. - The company is recognized as one of the most comprehensive enterprises in the commercialization of bio-based products through synthetic biology, being the first globally to industrialize the anaerobic fermentation of a series of amino acids, including L-Alanine and L-Valine. By 2024, it is projected to hold the largest market share for L-Alanine and L-Valine globally [3]. Product Portfolio - As of June 30, 2025, Huaheng Bio has established stable long-term partnerships with over 768 customers across 85 countries in Asia, Europe, and the Americas. Its main bio-based products include amino acids (primarily alanine series, L-Valine, tryptophan, arginine), vitamins (D-Calcium Pantothenate, D-Pantothenol, inositol), and other bio-based products (1,3-propanediol, succinic acid, malic acid, arbutin) [4]. - The company employs two green manufacturing technology platforms: fermentation and enzyme catalysis, focusing on microbial cell factories and enzyme-based production processes to reduce pollution, lower energy consumption, and minimize carbon footprints [4]. Market Potential - The global bio-based products market is expected to grow from $22.8 billion in 2020 to $42.1 billion by 2024, with a compound annual growth rate (CAGR) of 16.6%. It is projected to further increase to $80.1 billion by 2030 and $109.1 billion by 2035, with CAGRs of 11.3% and 6.4% respectively [5]. - Companies with green manufacturing capabilities, large-scale production technologies, and collaborative advantages in the supply chain are anticipated to experience unprecedented growth opportunities in this market [5]. Financial Performance - The company reported revenues of approximately RMB 1.419 billion, RMB 1.938 billion, RMB 2.178 billion, and RMB 1.489 billion for the years 2022, 2023, 2024, and the first half of 2025, respectively. The corresponding profits for these periods were approximately RMB 319 million, RMB 447 million, RMB 185 million, and RMB 109 million [5][7].

Core Viewpoint - The article discusses the signing of a cooperation agreement between Inner Mongolia Kailu County and Anhui Fengyuan Group for the establishment of a green zero-carbon bio-manufacturing industrial base, with a total investment of 15.5 billion yuan and projected annual sales revenue of approximately 26 billion yuan upon full production [2]. Group 1: Project Overview - The Fengyuan (Northern) Green Zero-Carbon Bio-Manufacturing Industrial Base Project includes three main sectors: amino acid series products, bio-materials, and bio-energy [2]. - The project is expected to generate an annual sales revenue of around 26 billion yuan once fully operational [2]. Group 2: Technological Innovations - Fengyuan Group has developed first and second-generation bio-manufacturing technologies, utilizing starch sugar and straw for sugar production, respectively [2]. - The company has established four major innovative technology platforms: 1. Technology for producing plant-based humic acid from cellulose derived from agricultural and forestry waste [2]. 2. Three bio-based material platform technologies, including polylactic acid, bio-based polyurethane, and bio-based polycarbonate [2]. 3. Three bio-energy manufacturing technologies, including cellulose ethanol, biodiesel, and bio-jet fuel [2]. 4. Downstream application technologies for bio-based materials, covering a wide range of products such as bio-fibers, bio-plastics, and bio-based construction materials [2]. Group 3: Company Background - Fengyuan Group is a mixed-ownership enterprise with state-owned shares, focusing on the R&D and industrialization of bio-chemicals, bio-materials, bio-energy, and bio-pharmaceuticals [3]. - The company controls Fengyuan Pharmaceutical and holds shares in Yunding Technology, along with several other subsidiaries in various sectors [3]. - Fengyuan Group has established bio-manufacturing plants in Thailand, Hungary, and Brazil, producing organic acids and amino acids for food and feed additives [3].

Core Viewpoint - The corn industry is a strategic pillar for China's food security, with significant growth in planting area, yield, and total production expected in 2024, despite short-term market adjustments due to international price fluctuations and rising costs [1][8][14]. Group 1: Industry Overview - The corn processing industry in China has developed a complete industrial chain, from primary processing to modern biobased material research, becoming a key hub for agricultural production and industrial manufacturing [1][5][14]. - Corn processing can be categorized into primary processing and deep processing, producing various products for food, feed, and industrial applications [2][3][5]. Group 2: Current Development Status - In 2024, China's corn planting area is projected to reach 44.74 million hectares, a year-on-year increase of 1.18%, with a yield of 439.4 kg/mu, contributing to a total production of 294.92 million tons, a 2.1% increase from the previous year [1][8][10]. - The total corn consumption in 2024 is expected to reach 31.78 million tons, with industrial consumption growing by 3.07% to 7.94 million tons, driven by innovations in deep processing [12][14]. Group 3: Market Trends - The corn deep processing market size is expected to adjust to 190 billion yuan in 2024, down 6.4% from its peak in 2022, but the long-term growth trend remains solid [1][14]. - The corn processing industry is transitioning towards green and low-carbon practices, focusing on high-value product development such as polylactic acid and functional sugars [24][25][26]. Group 4: Competitive Landscape - The corn deep processing industry in China has a tiered competitive structure, with leading companies like COFCO Technology and Meihua Biological occupying the top tier, focusing on high-value products [20][22]. - The market for corn starch is highly concentrated, with top companies holding over 44% market share, and there is a trend towards differentiation and expansion into biobased materials and other emerging fields [22][24].